Sleep Medicine Gains Recognition as Central to Overall Health
Growing evidence links sleep disorders to a range of conditions, elevating sleep from lifestyle concern to medical priority.
Sleep medicine is gaining recognition as central to overall health, as a growing body of evidence links sleep disorders to a wide range of conditions and elevates sleep from a lifestyle footnote to a genuine medical priority.
Research has steadily strengthened the connections between poor or disordered sleep and outcomes across the body, from cardiovascular and metabolic health to mood, cognition, and immune function. Sleep, it turns out, is not downtime but active, essential maintenance.
Underdiagnosed disorders
Common sleep disorders, notably sleep apnea, remain substantially underdiagnosed, leaving many people to suffer effects they may not connect to their sleep. Greater awareness among both clinicians and patients is helping more of them get evaluated and treated.
Advances in diagnosis and treatment have made care more accessible, including home-based sleep testing and more comfortable therapies. Addressing a sleep disorder can yield benefits that ripple across a person's health and daily functioning.
Mainstreaming sleep
Clinicians increasingly ask about sleep as a routine part of care, recognizing it as a vital sign of sorts. The broader message, experts say, is that prioritizing sleep is not indulgence but medicine, and that treating sleep seriously is one of the more consequential shifts in preventive health.
More in Health & Medicine
FDA Licenses the First Freeze-Dried Plasma Product in the U.S.
Regulators approved the country's first freeze-dried plasma, a shelf-stable blood product that could ease transfusion logistics in trauma care and emergency settings.
Health Officials Investigate a Multistate Cyclospora Outbreak Tied to Produce
Federal investigators are working to pin down the source of a cyclosporiasis outbreak reported across several states, a recurring summertime challenge linked to fresh produce.
FDA Advisory Panel Backs Compounding of Two Peptides, Drawing Expert Caution
A federal advisory committee recommended allowing two peptides to be compounded, but specialists warned the move could be misread as a sign the compounds have been fully vetted.